What is Cnl Healthcare's earnings per share (EPS)?

Cnl Healthcare (CHTH) reported diluted earnings per share of $-0.08 for fiscal year 2024. This represents a 46.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Cnl Healthcare Financials

CHTH

Source SEC Filings (10-K/10-Q) Data as of Sep 30, 2025 Currency USD FYE December

This page shows Cnl Healthcare (CHTH) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CHTH FY2024 2026-04-22

Revenue growth is rebuilding operating profit, but interest-heavy financing still keeps accounting earnings negative.

Operating margin widened from 4.0% to 8.5% in the latest year, showing the asset base produced a much better operating spread after several years of thin profitability. But interest expense reached $45.9M while operating cash flow was only $40.3M, so financing costs still consumed more cash than the business generated before investing.

After the dividend reset from $35.6M to about $17.8M, operating cash flow has covered it in each of the last three years. That suggests distributions are now sized to recurring cash generation rather than to accounting earnings, which are heavily damped by depreciation.

Long-term debt slipped to $569.9M, yet debt-to-equity still increased because equity kept shrinking with repeated losses. Total assets also fell over the period, which means some balance-sheet repair came from asset reduction rather than from profit rebuilding or internally generated cash retention.

Financial Health Signals

Financial health score pending refresh

We are recalculating Cnl Healthcare's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.

Piotroski F-Score Partial

5/7

Cnl Healthcare passes 5 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Mixed

-2.79x

For every $1 of reported earnings, Cnl Healthcare generates $-2.79 in operating cash flow ($40.3M OCF vs -$14.5M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Interest Coverage At Risk

0.7x

Cnl Healthcare earns $0.7 in operating income for every $1 of interest expense ($30.9M vs $45.9M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$366.0M

YoY+7.2%

5Y CAGR+2.3%

10Y CAGR+7.3%

Cnl Healthcare generated $366.0M in revenue in fiscal year 2024. This represents an increase of 7.2% from the prior year.

EBITDA

$81.6M

YoY+25.7%

5Y CAGR-2.3%

10Y CAGR+7.4%

Cnl Healthcare's EBITDA was $81.6M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 25.7% from the prior year.

Net Income

-$14.5M

YoY+43.7%

Cnl Healthcare reported -$14.5M in net income in fiscal year 2024. This represents an increase of 43.7% from the prior year.

EPS (Diluted)

$-0.08

YoY+46.7%

Cnl Healthcare earned $-0.08 per diluted share (EPS) in fiscal year 2024. This represents an increase of 46.7% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$44.0M

YoY-18.6%

5Y CAGR+0.8%

10Y CAGR-7.0%

Cnl Healthcare held $44.0M in cash against $569.9M in long-term debt as of fiscal year 2024.

Dividends Per Share

$0.10

YoY+0.0%

5Y CAGR-46.2%

10Y CAGR-12.9%

Cnl Healthcare paid $0.10 per share in dividends in fiscal year 2024. This represents an increase of 0.0% from the prior year.

Shares Outstanding

175M

YoY+0.0%

5Y CAGR+0.2%

10Y CAGR+4.2%

Cnl Healthcare had 175M shares outstanding in fiscal year 2024. This represents an increase of 0.0% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

8.5%

YoY+4.5pp

5Y CAGR-4.3pp

10Y CAGR+21.3pp

Cnl Healthcare's operating margin was 8.5% in fiscal year 2024, reflecting core business profitability. This is up 4.5 percentage points from the prior year.

Net Margin

-4.0%

YoY+3.6pp

5Y CAGR-111.7pp

10Y CAGR+25.1pp

Cnl Healthcare's net profit margin was -4.0% in fiscal year 2024, showing the share of revenue converted to profit. This is up 3.6 percentage points from the prior year.

Return on Equity

-2.0%

YoY+1.4pp

5Y CAGR-41.1pp

10Y CAGR+4.0pp

Cnl Healthcare's ROE was -2.0% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is up 1.4 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

CHTH Income Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Revenue	$366.0M+7.2%	$341.5M+5.8%	$322.7M+9.2%	$295.4M-3.8%	$307.1M-5.8%	$326.1M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$8.8M-3.8%	$9.1M-10.9%	$10.2M+12.0%	$9.1M-3.2%	$9.4M-28.8%	$13.2M
Operating Income	$30.9M+126.3%	$13.7M+54.0%	$8.9M+5111.3%	-$177K-100.8%	$21.7M-47.8%	$41.6M
Interest Expense	$45.9M+9.5%	$41.9M+92.2%	$21.8M+10.6%	$19.7M-18.9%	$24.3M-38.7%	$39.6M
Income Tax	$611K+9.1%	$560K+3.7%	$540K-87.1%	$4.2M+280.1%	$1.1M-50.3%	$2.2M
Net Income	-$14.5M+43.7%	-$25.7M-1668.6%	-$1.5M+93.7%	-$22.9M-684.9%	$3.9M-98.9%	$351.5M
EPS (Diluted)	$-0.08+46.7%	$-0.15-1400.0%	$-0.01+92.3%	$-0.13-1400.0%	$0.01	N/A

Metric	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23
Revenue	$99.3M+2.0%	$97.4M+1.8%	$95.6M+2.6%	$93.2M+0.4%	$92.8M+2.1%	$90.9M+2.0%	$89.1M+3.1%	$86.4M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$2.5M+16.3%	$2.2M-6.6%	$2.3M-6.9%	$2.5M+36.2%	$1.8M-16.1%	$2.2M-1.0%	$2.2M-12.5%	$2.5M
Operating Income	$9.4M-1.3%	$9.6M+12.8%	$8.5M+32.4%	$6.4M-21.4%	$8.1M-18.9%	$10.0M+58.6%	$6.3M+266.4%	$1.7M
Interest Expense	$10.9M-0.9%	$11.0M+0.5%	$11.0M-2.7%	$11.3M-2.0%	$11.5M+0.7%	$11.4M-1.3%	$11.6M+3.6%	$11.2M
Income Tax	$181K+17.5%	$154K-4.9%	$162K-34.7%	$248K+98.4%	$125K+1.6%	$123K+7.0%	$115K-51.9%	$239K
Net Income	-$1.6M-5.8%	-$1.5M+41.9%	-$2.6M+48.1%	-$5.0M-56.0%	-$3.2M-143.8%	-$1.3M+74.1%	-$5.0M+44.8%	-$9.1M
EPS (Diluted)	$-0.010.0%	$-0.010.0%	$-0.01	N/A	$-0.02-100.0%	$-0.01+66.7%	$-0.03	N/A

CHTH Balance Sheet

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Total Assets	$1.3B-3.4%	$1.4B-5.0%	$1.4B+0.1%	$1.4B-4.5%	$1.5B-7.0%	$1.6B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$44.0M-18.6%	$54.1M-22.2%	$69.5M+30.7%	$53.2M-13.5%	$61.5M+45.2%	$42.4M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$607.6M-2.2%	$621.5M-3.9%	$647.0M+3.4%	$625.8M-1.4%	$634.7M-11.3%	$715.4M
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	$569.9M-2.6%	$584.8M-4.1%	$609.9M+2.9%	$592.8M-1.6%	$602.5M-11.7%	$682.3M
Total Equity	$711.8M-4.3%	$743.6M-5.8%	$789.8M-2.4%	$809.0M-6.7%	$867.5M-3.5%	$899.2M
Retained Earnings	$60.2M-19.4%	$74.7M-25.6%	$100.4M-1.4%	$101.9M-18.3%	$124.7M+3.2%	$120.8M

Metric	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23
Total Assets	$1.3B-0.1%	$1.3B-0.8%	$1.3B-0.4%	$1.3B-1.2%	$1.3B-0.4%	$1.3B-0.4%	$1.3B-1.5%	$1.4B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$57.7M+8.5%	$53.2M+4.4%	$50.9M+15.8%	$44.0M-12.9%	$50.5M+2.9%	$49.1M+15.9%	$42.4M-21.7%	$54.1M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$608.1M+0.8%	$603.1M-0.9%	$608.6M+0.2%	$607.6M-1.2%	$614.7M+1.2%	$607.3M0.0%	$607.3M-2.3%	$621.5M
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	$565.0M0.0%	$565.0M-0.9%	$570.0M0.0%	$569.9M-0.8%	$574.2M0.0%	$574.4M0.0%	$574.6M-1.7%	$584.8M
Total Equity	$693.6M-0.8%	$699.5M-0.8%	$704.9M-1.0%	$711.8M-1.2%	$720.1M-1.7%	$732.3M-0.7%	$737.6M-0.8%	$743.6M
Retained Earnings	$54.6M-2.8%	$56.2M-2.6%	$57.7M-4.3%	$60.2M-7.6%	$65.2M-4.6%	$68.4M-1.9%	$69.7M-6.7%	$74.7M

CHTH Cash Flow Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Operating Cash Flow	$40.3M+26.1%	$32.0M-27.1%	$43.8M-5.4%	$46.4M-26.5%	$63.1M+5.3%	$60.0M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$16.1M-274.5%	$9.3M+249.6%	-$6.2M+8.3%	-$6.7M-109.7%	$69.9M-94.8%	$1.4B
Financing Cash Flow	-$34.4M+41.5%	-$58.9M-170.6%	-$21.8M+54.6%	-$47.9M+58.5%	-$115.6M+91.9%	-$1.4B
Dividends Paid	$17.8M0.0%	$17.8M0.0%	$17.8M-50.0%	$35.6M0.0%	$35.6M-91.0%	$394.9M
Share Buybacks	N/A	N/A	N/A	$0	$0-100.0%	$23K

Metric	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23
Operating Cash Flow	$13.4M-16.9%	$16.2M+13.0%	$14.3M+53.4%	$9.3M-9.6%	$10.3M-23.6%	$13.5M+88.9%	$7.1M-2.6%	$7.3M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$4.4M+2.2%	-$4.5M-99.6%	-$2.3M+67.6%	-$7.0M-98.3%	-$3.5M-17.5%	-$3.0M-12.9%	-$2.7M-127.6%	$9.6M
Financing Cash Flow	-$4.5M+52.9%	-$9.5M-117.9%	-$4.3M+57.9%	-$10.3M-115.5%	-$4.8M-2.3%	-$4.7M+68.2%	-$14.7M+12.3%	-$16.7M
Dividends Paid	$4.5M0.0%	$4.5M0.0%	$4.5M0.0%	$4.5M0.0%	$4.5M0.0%	$4.5M0.0%	$4.5M0.0%	$4.5M
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

CHTH Financial Ratios

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	8.5%+4.5pp	4.0%+1.3pp	2.8%+2.8pp	-0.1%-7.1pp	7.1%-5.7pp	12.8%
Net Margin	-4.0%+3.6pp	-7.5%-7.1pp	-0.4%+7.3pp	-7.8%-9.0pp	1.3%-106.5pp	107.8%
Return on Equity	-2.0%+1.4pp	-3.5%-3.3pp	-0.2%+2.6pp	-2.8%-3.3pp	0.4%-38.6pp	39.1%
Return on Assets	-1.1%+0.8pp	-1.9%-1.8pp	-0.1%+1.5pp	-1.6%-1.9pp	0.3%-21.5pp	21.8%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	0.80+0.0	0.79+0.0	0.77+0.0	0.73+0.0	0.69-0.1	0.76
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	9.5%-0.3pp	9.8%+1.0pp	8.8%+2.0pp	6.9%-1.9pp	8.8%-2.3pp	11.1%+3.9pp	7.1%+5.1pp	2.0%
Net Margin	-1.6%-0.1pp	-1.5%+1.2pp	-2.7%+2.6pp	-5.3%-1.9pp	-3.4%-2.0pp	-1.4%+4.2pp	-5.7%+4.9pp	-10.5%
Return on Equity	-0.2%-0.0pp	-0.2%+0.1pp	-0.4%+0.3pp	-0.7%-0.3pp	-0.4%-0.3pp	-0.2%+0.5pp	-0.7%+0.5pp	-1.2%
Return on Assets	-0.1%0.0pp	-0.1%+0.1pp	-0.2%+0.2pp	-0.4%-0.1pp	-0.2%-0.1pp	-0.1%+0.3pp	-0.4%+0.3pp	-0.7%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	0.810.0	0.810.0	0.810.0	0.800.0	0.80+0.0	0.780.0	0.780.0	0.79
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Frequently Asked Questions

What is Cnl Healthcare's annual revenue?

Cnl Healthcare (CHTH) reported $366.0M in total revenue for fiscal year 2024. This represents a 7.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Cnl Healthcare's revenue growing?

Cnl Healthcare (CHTH) revenue grew by 7.2% year-over-year, from $341.5M to $366.0M in fiscal year 2024.

Is Cnl Healthcare profitable?

No, Cnl Healthcare (CHTH) reported a net income of -$14.5M in fiscal year 2024, with a net profit margin of -4.0%.

What is Cnl Healthcare's EBITDA?

Cnl Healthcare (CHTH) had EBITDA of $81.6M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Cnl Healthcare have?

As of fiscal year 2024, Cnl Healthcare (CHTH) had $44.0M in cash and equivalents against $569.9M in long-term debt.

What is Cnl Healthcare's operating margin?

Cnl Healthcare (CHTH) had an operating margin of 8.5% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.

What is Cnl Healthcare's net profit margin?

Cnl Healthcare (CHTH) had a net profit margin of -4.0% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

Does Cnl Healthcare pay dividends?

Yes, Cnl Healthcare (CHTH) paid $0.10 per share in dividends during fiscal year 2024.

What is Cnl Healthcare's return on equity (ROE)?

Cnl Healthcare (CHTH) has a return on equity of -2.0% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.

What is Cnl Healthcare's operating cash flow?

Cnl Healthcare (CHTH) generated $40.3M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

What are Cnl Healthcare's total assets?

Cnl Healthcare (CHTH) had $1.3B in total assets as of fiscal year 2024, including both current and long-term assets.

How many shares does Cnl Healthcare have outstanding?

Cnl Healthcare (CHTH) had 175M shares outstanding as of fiscal year 2024.

What is Cnl Healthcare's debt-to-equity ratio?

Cnl Healthcare (CHTH) had a debt-to-equity ratio of 0.80 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Cnl Healthcare's return on assets (ROA)?

Cnl Healthcare (CHTH) had a return on assets of -1.1% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is Cnl Healthcare's Piotroski F-Score?

Cnl Healthcare (CHTH) has a Piotroski F-Score of 5 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Cnl Healthcare's earnings high quality?

Cnl Healthcare (CHTH) has an earnings quality ratio of -2.79x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Cnl Healthcare cover its interest payments?

Cnl Healthcare (CHTH) has an interest coverage ratio of 0.7x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.